Redox control of protein kinase C: Cell-and disease-specific aspects

Antioxidants and Redox Signaling

Volumn 13, Issue 7, 2010, Pages 1051-1085

  Giorgi, Carlotta ^a   Agnoletto, Chiara ^a   Baldini, Claudio ^a   Bononi, Angela ^a   Bonora, Massimo ^a   Marchi, Saverio ^a   Missiroli, Sonia ^a   Patergnani, Simone ^a   Poletti, Federica ^a   Rimessi, Alessandro ^a   Zavan, Barbara ^b   Pinton, Paolo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 12 0 TETRADECANOYLPHORBOL 13 ACETATE; ALCOHOL; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL SUCCINATE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BETA CAROTENE; CALPHOSTIN C; CARBON TETRACHLORIDE; CATECHOL; CYTARABINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GLUTATHIONE; HISPIDIN; HYDROQUINONE; HYPERICIN; METFORMIN; PHORBOL DERIVATIVE; PHORBOL ESTER; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C BETA INHIBITOR; PROTEIN KINASE C INHIBITOR; RASAGILINE; REACTIVE OXYGEN METABOLITE; RETINOID DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

AGING; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOPHAGY; CELL CYCLE REGULATION; CELL DEATH; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHEMOPROPHYLAXIS; CYTOLOGY; CYTOTOXICITY; DIABETES MELLITUS; DIGESTIVE SYSTEM CANCER; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVITY; GENE EXPRESSION; HEALTH; HEART MUSCLE ISCHEMIA; HIPPOCAMPUS; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; NEOPLASM; NERVE CELL; NEUROPROTECTION; NONHUMAN; OSTEOBLAST; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; VASODILATATION;

ANIMALS; APOPTOSIS; AUTOPHAGY; CALCIUM; CELL AGING; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DIABETES MELLITUS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MESENCHYMAL STEM CELLS; MYOCARDIAL REPERFUSION INJURY; NEOPLASMS; NEURONS; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 77955916237     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2825     Document Type: Review

References (287)

1. Aguiari P, Leo S, Zavan B, Vindigni V, Rimessi A, Bianchi K, Franzin C, Cortivo R, Rossato M, Vettor R, Abatangelo G, Pozzan T, Pinton P, and Rizzuto R. High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci USA 105: 1226-1231, 2008.
2. Akman SA, Kensler TW, Doroshow JH, and Dizdaroglu M. Copper ion-mediated modification of bases in DNA in vitro by benzoyl peroxide. Carcinogenesis 14: 1971-1974, 1993.
3. Albanes D, Heinonen OP, Huttunen JK, Taylor PR, Virtamo J, Edwards BK, Haapakoski J, Rautalahti M, Hartman AM, Palmgren J, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 62: 1427S-1430S, 1995.
4. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, and Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 93: 13742-13747, 1996.
5. Alonso M, Medina JH, and Pozzo-Miller L. ERK1=2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn Mem 11: 172-178, 2004.
6. Alvaro V, Levy L, Dubray C, Roche A, Peillon F, Querat B, and Joubert D. Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C. J Clin Endocrinol Metab 77: 1125-1129, 1993.
7. Anisimov VN. Effects of exogenous melatonin\A review. Toxicol Pathol 31: 589-603, 2003.
8. Arguin G, Regimbald-Dumas Y, Fregeau MO, Caron AZ, and Guillemette G. Protein kinase C phosphorylates the inositol 1,4,5-trisphosphate receptor type 2 and decreases the mobilization of Ca2\+ in pancreatoma AR4-2J cells. J Endocrinol 192: 659-668, 2007. (Pubitemid 46455968)
9. Ashkenazi A and Dixit VM. Death receptors: Signaling and modulation. Science 281: 1305-1308, 1998.
10. Azevedo-Martins AK, Lortz S, Lenzen S, Curi R, Eizirik DL, and Tiedge M. Improvement of the mitochondrial an-tioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells. Diabetes 52: 93-101, 2003.
11. Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL, Guo Y, Bolli R, Cardwell EM, and Ping P. Protein ki-nase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 92: 873-880, 2003.
12. Bansode RR, Huang W, Roy SK, Mehta M, and Mehta KD. Protein kinase C deficiency increases fatty acid oxidation and reduces fat storage. J Biol Chem 283: 231-236, 2008.
13. Barsacchi R, Coassin M, Maiorino M, Pelosi G, Simonelli C, and Ursini F. Increased ultra weak chemiluminescence emission from rat heart at postischemic reoxygenation: Protective role of vitamin E. Free Radic Biol Med 6: 573-579, 1989.
14. Berra E, Diaz-Meco MT, Dominguez I, Municio MM, Sanz L, Lozano J, Chapkin RS, and Moscat J. Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell 74: 555-563, 1993.
15. Bertolotto C, Maulon L, Filippa N, Baier G, and Auberger P. Protein kinase C theta and epsilon promote T-cell survival by a rsk-dependent phosphorylation and inactivation of BAD. J Biol Chem 275: 37246-37250, 2000.
16. Bezombes C, de Thonel A, Apostolou A, Louat T, Jaffrezou JP, Laurent G, and Quillet-Mary A. Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activation. Mol Pharmacol 62: 1446-1455, 2002.
17. Bezombes C, Plo I, Mansat-De Mas V, Quillet-Mary A, Negre-Salvayre A, Laurent G, and Jaffrezou JP. Oxidative stress-induced activation of Lyn recruits sphingomyelinase and is requisite for its stimulation by Ara-C. FASEB J 15: 1583-1585, 2001.
18. Bi N and Mamrack MD. PMA inhibits the growth of human fibroblasts after the induction of immediate-early genes. Exp Cell Res 212: 105-112, 1994.
19. Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, and Shoulson I. Rasagiline improves quality of life in patients with early Parkinson's disease. Mov Disord 21: 616-623, 2006.
20. Bjelakovic G, Nikolova D, Simonetti RG, and Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet 364: 1219-1228, 2004.
21. Black JD. Protein kinase C-mediated regulation of the cell cycle. Front Biosci 5: D406-423, 2000.
22. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, and Green MS. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial. Lancet 356: 1213-1218, 2000.
23. Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P, Konietzka I, Lopez-Iglesias C, Garcia-Dorado D, Di Lisa F, Heusch G, and Schulz R. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res 67: 234-244, 2005.
24. Bouloumie A, Marumo T, Lafontan M, and Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 13: 1231-1238, 1999.
25. Bowling N, Huang X, Sandusky GE, Fouts RL, Mintze K, Esterman M, Allen PD, Maddi R, McCall E, and Vlahos CJ. Protein kinase C-alpha and-epsilon modulate connexin-43 phosphorylation in human heart. J Mol Cell Cardiol 33: 789-798, 2001.
26. Brasier AR, Jamaluddin M, Han Y, Patterson C, and Runge MS. Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor. Mol Cell Biochem 212: 155-169, 2000.
27. Brunner F. Dependence of endothelin-1 secretion on Ca2\+. Biochem Pharmacol 49: 1785-1791, 1995.
28. Budas GR, Churchill EN, and Mochly-Rosen D. Cardio-protective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury. Pharmacol Res 55: 523-536, 2007.
29. Caron AZ, Chaloux B, Arguin G, and Guillemette G. Protein kinase C decreases the apparent affinity of the inositol 1,4,5-trisphosphate receptor type 3 in RINm5F cells. Cell Calcium 42: 323-331, 2007.
30. Carter CA and Kane CJ. Therapeutic potential of natural compounds that regulate the activity of protein kinase C. Curr Med Chem 11: 2883-2902, 2004.
31. Chalfant CE, Ohno S, Konno Y, Fisher AA, Bisnauth LD, Watson JE, and Cooper DR. A carboxy-terminal deletion mutant of protein kinase C beta II inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells. Mol Endocrinol 10: 1273-1281, 1996.
32. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, and Mochly-Rosen D. Activation of aldehyde dehy-drogenase-2 reduces ischemic damage to the heart. Science 321: 1493-1495, 2008.
33. Chen CT, Hsu SH, and Wei YH. Upregulation of mito-chondrial function and antioxidant defense in the differentiation of stem cells. Biochim Biophys Acta 1800: 257-263, 2009.
34. Chen CT, Shih YR, Kuo TK, Lee OK, and Wei YH. Coordinated changes of mitochondrial biogenesis and antioxi-dant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 26: 960-968, 2008.
35. Chen HC, Bandyopadhyay G, Sajan MP, Kanoh Y, Stan-daert M, Farese RV, Jr., and Farese RV. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise-and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport. J Biol Chem 277: 23554-23562, 2002.
36. Chen JL, Lin HH, Kim KJ, Lin A, Forman HJ, and Ann DK. Novel roles for protein kinase Cdelta-dependent signaling pathways in acute hypoxic stress-induced autophagy. J Biol Chem 283: 34432-34444, 2008.
37. Chen JL, Lin HH, Kim KJ, Lin A, Ou JH, and Ann DK. PKC delta signaling: A dual role in regulating hypoxic stress-induced autophagy and apoptosis. Autophagy 5: 244-246, 2009.
38. Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW, 2nd, and Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci USA 98: 11114-11119, 2001.
39. Chmura SJ, Nodzenski E, Weichselbaum RR, and Quintans J. Protein kinase C inhibition induces apoptosis and cer-amide production through activation of a neutral sphin-gomyelinase. Cancer Res 56: 2711-2714, 1996.
40. Chou WH and Messing RO. Protein kinase C isozymes in stroke. Trends Cardiovasc Med 15: 47-51, 2005.
41. Christodoulides C, Lagathu C, Sethi JK, and Vidal-Puig A. Adipogenesis and WNT signaling. Trends Endocrinol Metab 20: 16-24, 2009.
42. Churchill EN, Murriel CL, Chen CH, Mochly-Rosen D, and Szweda LI. Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circ Res 97: 78-85, 2005.
43. Churchill EN and Szweda LI. Translocation of deltaPKC to mitochondria during cardiac reperfusion enhances super-oxide anion production and induces loss in mitochondrial function. Arch Biochem Biophys 439: 194-199, 2005.
44. Clapham DE. Calcium signaling. Cell 131: 1047-1058, 2007.
45. Clapp-Lilly KL, Smith MA, Perry G, Harris PL, Zhu X, and Duffy LK. Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease. Neuroreport 12: 1277-1280, 2001.
46. Costa AD, Jakob R, Costa CL, Andrukhiv K, West IC, and Garlid KD. The mechanism by which the mitochondrial ATP-sensitive K\+ channel opening and H2O2 inhibit the mitochondrial permeability transition. J Biol Chem 281: 20801-20808, 2006.
47. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, and Lord JM. Serine=threonine protein kinases and apoptosis. Exp Cell Res 256: 34-41, 2000.
48. Cuervo AM. Autophagy: In sickness and in health. Trends Cell Biol 14: 70-77, 2004.
49. Da Cruz e Silva OA, Rebelo S, Vieira SI, Gandy S, da Cruz e Silva EF, and Greengard P. Enhanced generation of Alzheimer's amyloid-beta following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C. J Neurochem 108: 319-330, 2009.
50. Dalton TP, Shertzer HG, and Puga A. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 39: 67-101, 1999.
51. Das Evcimen N, and King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 55: 498-510, 2007.
52. Davis PJ and Davis FB. Nongenomic actions of thyroid hormone on the heart. Thyroid 12: 459-466, 2002.
53. Denning MF, Dlugosz AA, Threadgill DW, Magnuson T, and Yuspa SH. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta. J Biol Chem 271: 5325-5331, 1996.
54. Detjen KM, Brembeck FH, Welzel M, Kaiser A, Haller H, Wiedenmann B, and Rosewicz S. Activation of protein ki-nase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest. J Cell Sci 113: 3025-3035, 2000.
55. Doble BW, Ping P, and Kardami E. The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res 86: 293-301, 2000.
56. Domenicotti C, Paola D, Vitali A, Nitti M, Cottalasso D, Melloni E, Poli G, Marinari UM, and Pronzato MA. Mechanisms of inactivation of hepatocyte protein kinase C isoforms following acute ethanol treatment. Free Radic Biol Med 25: 529-535, 1998.
57. Doolan CM, Condliffe SB, and Harvey BJ. Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca(2\+)](i) by 17beta-oestradiol in female rat distal colon. Br J Pharmacol 129: 1375-1386, 2000.
58. Dorn GW, 2nd, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, Csukai M, Wu G, Lorenz JN, and Mochly-Rosen D. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci USA 96: 12798-12803, 1999.
59. Dos Santos P, Kowaltowski AJ, Laclau MN, Seetharaman S, Paucek P, Boudina S, Thambo JB, Tariosse L, and Garlid KD. Mechanisms by which opening the mitochondrial ATP-sensitive K(\+) channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 283: H284-295, 2002.
60. Doughan AK, Harrison DG, and Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: Linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102: 488-496, 2008.
61. Dries DR, Gallegos LL, and Newton AC. A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production. J Biol Chem 282: 826-830, 2007.
62. Eisen A, Fisman EZ, Rubenfire M, Freimark D, McKechnie R, Tenenbaum A, Motro M, and Adler Y. Ischemic preconditioning: Nearly two decades of research. A comprehensive review. Atherosclerosis 172: 201-210, 2004.
63. Eriksson JW. Metabolic stress in insulin's target cells leads to ROS accumulation. A hypothetical common pathway causing insulin resistance. FEBS Lett 581: 3734-3742, 2007.
64. Esler WP and Wolfe MS. A portrait of Alzheimer secre-tases\New features and familiar faces. Science 293: 1449-1454, 2001.
65. Etcheberrigaray R, Tan M, Dewachter I, Kuiperi C, Van der Auwera I, Wera S, Qiao L, Bank B, Nelson TJ, Kozikowski AP, Van Leuven F, and Alkon DL. Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice. Proc Natl Acad Sci USA 101: 11141-11146, 2004.
66. Farese RV, Sajan MP, and Standaert ML. Atypical protein kinase C in insulin action and insulin resistance. Biochem Soc Trans 33: 350-353, 2005.
67. Farese RV, Sajan MP, Yang H, Li P, Mastorides S, Gower WR, Jr., Nimal S, Choi CS, Kim S, Shulman GI, Kahn CR, Braun U, and Leitges M. Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes. J Clin Invest 117: 2289-2301, 2007.
68. Ferris CD, Huganir RL, Bredt DS, Cameron AM, and Snyder SH. Inositol trisphosphate receptor: Phospho-rylation by protein kinase C and calcium calmodulin-dependent protein kinases in reconstituted lipid vesicles. Proc Natl Acad Sci USA 88: 2232-2235, 1991.
69. Filomenko R, Poirson-Bichat F, Billerey C, Belon JP, Gar-rido C, Solary E, and Bettaieb A. Atypical protein kinase C zeta as a target for chemosensitization of tumor cells. Cancer Res 62: 1815-1821, 2002.
70. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 15: 247-254, 2003.
71. Finkel T and Holbrook NJ. Oxidants, oxidative stress and the biology of aging. Nature 408: 239-247, 2000.
72. Flaherty JT, Pitt B, Gruber JW, Heuser RR, Rothbaum DA, Burwell LR, George BS, Kereiakes DJ, Deitchman D, and Gustafson N, et al. Recombinant human superoxide dis-mutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 89: 1982-1991, 1994.
73. Formisano P, Oriente F, Fiory F, Caruso M, Miele C, Maitan MA, Andreozzi F, Vigliotta G, Condorelli G, and Beguinot F. Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells. Mol Cell Biol 20: 6323-6333, 2000.
74. Frojdo S, Vidal H, and Pirola L. Alterations of insulin signaling in type 2 diabetes: A review of the current evidence from humans. Biochim Biophys Acta 1792: 83-92, 2009.
75. Fryer RM, Wang Y, Hsu AK, and Gross GJ. Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 280: H1346-1353, 2001.
76. Fusco D, Colloca G, Lo Monaco MR, and Cesari M. Effects of antioxidant supplementation on the aging process. Clin Interv Aging 2: 377-387, 2007.
77. Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Naka-mura K, Uchida K, Kitaguchi T, Takahashi-Iwanaga H, Noda T, Aruga J, and Mikoshiba K. IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309: 2232-2234, 2005.
78. Gallo A, Ceolotto G, Pinton P, Iori E, Murphy E, Rutter GA, Rizzuto R, Semplicini A, and Avogaro A. Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antiox-idant mechanism. Diabetes 54: 1123-1131, 2005.
79. Galluzzi L and Kroemer G. Mitochondrial apoptosis without VDAC. Nat Cell Biol 9: 487-489, 2007.
80. Gavrielides MV, Frijhoff AF, Conti CJ, and Kazanietz MG. Protein kinase C and prostate carcinogenesis: Targeting the cell cycle and apoptotic mechanisms. Curr Drug Targets 5: 431-443, 2004.
81. Gilgun-Sherki Y, Melamed E, and Offen D. Oxidative stress induced-neurodegenerative diseases: The need for antioxidants that penetrate the blood brain barrier. Neuro-pharmacology 40: 959-975, 2001.
82. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, and Pelicci PG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122: 221-233, 2005.
83. Gopalakrishna R and Anderson WB. Susceptibility of protein kinase C to oxidative inactivation: Loss of both phos-photransferase activity and phorbol diester binding. FEBS Lett 225: 233-237, 1987.
84. Gopalakrishna R and Anderson WB. Ca2\+-and phospho-lipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA 86: 6758-6762, 1989.
85. Gopalakrishna R, Chen ZH, and Gundimeda U. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem 268: 27180-27185, 1993.
86. Gopalakrishna R, Chen ZH, and Gundimeda U. Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells. Proc Natl Acad Sci USA 91: 12233-12237, 1994.
87. Gopalakrishna R, Chen ZH, and Gundimeda U. Modifications of cysteine-rich regions in protein kinase C induced by oxidant tumor promoters and enzyme-specific inhibitors. Methods Enzymol 252: 132-146, 1995.
88. Gopalakrishna R and Gundimeda U. Antioxidant regulation of protein kinase C in cancer prevention. J Nutr 132: 3819S-3823S, 2002.
89. Gopalakrishna R, Gundimeda U, Schiffman JE, and McNeill TH. A direct redox regulation of protein kinase C isoenzymes mediates oxidant-induced neuritogenesis in PC12 cells. J Biol Chem 283: 14430-14444, 2008.
90. Gopalakrishna R and Jaken S. Protein kinase C signaling and oxidative stress. Free Radic Biol Med 28: 1349-1361, 2000.
91. Gschwendt M, Kittstein W, and Marks F. Protein kinase C activation by phorbol esters: Do cysteine-rich regions and pseudosubstrate motifs play a role? Trends Biochem Sci 16: 167-169, 1991.
92. Gubina E, Rinaudo MS, Szallasi Z, Blumberg PM, and Mufson RA. Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression. Blood 91: 823-829, 1998.
93. Gundimeda U, Hara SK, Anderson WB, and Gopalakrishna R. Retinoids inhibit the oxidative modification of protein kinase C induced by oxidant tumor promoters. Arch Bio-chem Biophys 300: 526-530, 1993.
94. Guo D, Nguyen T, Ogbi M, Tawfik H, Ma G, Yu Q, Caldwell RW, and Johnson JA. Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection. Am J Physiol Heart Circ Phy-siol 293: H2219-2230, 2007.
95. Gutteridge JM and Halliwell B. Free radicals and antioxi-dants in the year 2000. A historical look to the future. Ann NY Acad Sci 899: 136-147, 2000.
96. Haass C and De Strooper B. The presenilins in Alzheimer's disease\Proteolysis holds the key. Science 286: 916-919, 1999.
97. Halestrap AP. Calcium, mitochondria and reperfusion injury: A pore way to die. Biochem Soc Trans 34: 232-237, 2006.
98. Halestrap AP, Clarke SJ, and Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion\A target for cardioprotection. Cardiovasc Res 61: 372-385, 2004.
99. Hara E, Smith R, Parry D, Tahara H, Stone S, and Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867, 1996.
100. Haramaki N, Packer L, Assadnazari H, and Zimmer G. Cardiac recovery during post-ischemic reperfusion is improved by combination of vitamin E with dihydrolipoic acid. Biochem Biophys Res Commun 196: 1101-1107, 1993.
101. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 11: 298-300, 1956.
102. He L, Sabet A, Djedjos S, Miller R, Sun X, Hussain MA, Radovick S, and Wondisford FE. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 137: 635-646, 2009.
103. Heichman KA and Roberts JM. Rules to replicate by. Cell 79: 557-562, 1994.
104. Herrlich P and Bohmer FD. Redox regulation of signal transduction in mammalian cells. Biochem Pharmacol 59: 35-41, 2000.
105. Hirai T and Chida K. Protein kinase Czeta (PKCzeta): Activation mechanisms and cellular functions. J Biochem 133: 1-7, 2003.
106. Holmuhamedov EL, Wang L, and Terzic A. ATP-sensitive K\+ channel openers prevent Ca2\+ overload in rat cardiac mitochondria. J Physiol 519: 347-360, 1999.
107. Honda K, Casadesus G, Petersen RB, Perry G, and Smith MA. Oxidative stress and redox-active iron in Alzheimer's disease. Ann NY Acad Sci 1012: 179-182, 2004. (Pubitemid 38453525)
108. Hoyer-Hansen M, Bastholm L, Szyniarowski P, Campa-nella M, Szabadkai G, Farkas T, Bianchi K, Fehrenbacher N, Elling F, Rizzuto R, Mathiasen IS, and Jaattela M. Control of macroautophagy by calcium, calmodulin-dependent ki-nase kinase-beta, and Bcl-2. Mol Cell 25: 193-205, 2007.
109. Hug H and Sarre TF. Protein kinase C isoenzymes: Divergence in signal transduction? Biochem J 291: 329-343, 1993.
110. Humphries MJ, Limesand KH, Schneider JC, Nakayama KI, Anderson SM, and Reyland ME. Suppression of apoptosis in the protein kinase Cdelta null mouse in vivo. J Biol Chem 281: 9728-9737, 2006.
111. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR, and Shulman GI. Mechanism by which met-formin reduces glucose production in type 2 diabetes. Diabetes 49: 2063-2069, 2000.
112. Inagaki K, Chen L, Ikeno F, Lee FH, Imahashi K, Bouley DM, Rezaee M, Yock PG, Murphy E, and Mochly-Rosen D. Inhibition of delta-protein kinase C protects against re-perfusion injury of the ischemic heart in vivo. Circulation 108: 2304-2307, 2003.
113. Inoue I, Nagase H, Kishi K, and Higuti T. ATP-sensitive K\+ channel in the mitochondrial inner membrane. Nature 352: 244-247, 1991.
114. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, and King GL. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272: 728-731, 1996.
115. Isohara T, Horiuchi A, Watanabe T, Ando K, Czernik AJ, Uno I, Greengard P, Nairn AC, and Suzuki T. Phosphor-ylation of the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein at Ser655 by a novel protein kinase. Biochem Biophys Res Commun 258: 300-305, 1999.
116. Itani SI, Zhou Q, Pories WJ, MacDonald KG, and Dohm GL. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 49: 1353-1358, 2000. (Pubitemid 30624237)
117. Janero DR and Burghardt B. Oxidative injury to myocardial membrane: Direct modulation by endogenous alpha-tocopherol. J Mol Cell Cardiol 21: 1111-1124, 1989.
118. Jarvis WD, Fornari FA, Jr., Browning JL, Gewirtz DA, Ko-lesnick RN, and Grant S. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J Biol Chem 269: 31685-31692, 1994.
119. Jin ZQ, Zhou HZ, Zhu P, Honbo N, Mochly-Rosen D, Messing RO, Goetzl EJ, Karliner JS, and Gray MO. Cardi-oprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol 282: H1970-1977, 2002.
120. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, and Sollott SJ. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mito-chondrial permeability transition pore. J Clin Invest 113: 1535-1549, 2004.
121. Kahlos K, Zhang J, Block ER, and Patel JM. Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells. Mol Cell Biochem 254: 47-54, 2003.
122. Kahn BB and Flier JS. Obesity and insulin resistance. J Clin Invest 106: 473-481, 2000.
123. Kaibuchi K, Takai Y, and Nishizuka Y. Protein kinase C and calcium ion in mitogenic response of macrophage-depleted human peripheral lymphocytes. J Biol Chem 260: 1366-1369, 1985.
124. Kanazawa T, Taneike I, Akaishi R, Yoshizawa F, Furuya N, Fujimura S, and Kadowaki M. Amino acids and insulin control autophagic proteolysis through different signaling pathways in relation to mTOR in isolated rat hepatocytes. J Biol Chem 279: 8452-8459, 2004.
125. Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Matsuhisa M, and Yamasaki Y. Oxidative stress and the JNK pathway in diabetes. Curr Diabetes Rev 1: 65-72, 2005.
126. Kaul S, Anantharam V, Yang Y, Choi CJ, Kanthasamy A, and Kanthasamy AG. Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in do-paminergic neuronal cells. J Biol Chem 280: 28721-28730, 2005.
127. Kaul S, Kanthasamy A, Kitazawa M, Anantharam V, and Kanthasamy AG. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP\+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur J Neurosci 18: 1387-1401, 2003.
128. Kemp BE and Pearson RB. Intrasteric regulation of protein kinases and phosphatases. Biochim Biophys Acta 1094: 67-76, 1991.
129. Kevin LG, Camara AK, Riess ML, Novalija E, and Stowe DF. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol 284: H566-574, 2003.
130. Khaliulin I, Clarke SJ, Lin H, Parker J, Suleiman MS, and Halestrap AP. Temperature preconditioning of isolated rat hearts\A potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mito-chondrial permeability transition pore. J Physiol 581: 1147-1161, 2007.
131. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, and Smithies O. Genetic control of blood pressure and the angiotensi-nogen locus. Proc Natl Acad Sci USA 92: 2735-2739, 1995.
132. King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79: 1527-1534, 2008.
133. Klein HH, Pich S, Lindert-Heimberg S, Nebendahl K, and Niedmann P. Failure of chronic, high-dose, oral vitamin E treatment to protect the ischemic, reperfused porcine heart. J Mol Cell Cardiol 25: 103-112, 1993.
134. Kloner RA and Rezkalla SH. Preconditioning, post-conditioning and their application to clinical cardiology. Cardiovasc Res 70: 297-307, 2006.
135. Konishi H, Tanaka M, Takemura Y, Matsuzaki H, Ono Y, Kikkawa U, and Nishizuka Y. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci USA 94: 11233-11237, 1997.
136. Konishi H, Yamauchi E, Taniguchi H, Yamamoto T, Matsuzaki H, Takemura Y, Ohmae K, Kikkawa U, and Nishizuka Y. Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci USA 98: 6587-6592, 2001.
137. Koya D and King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998.
138. Kozikowski AP, Chen Y, Subhasish T, Lewin NE, Blumberg PM, Zhong Z, D'Annibale MA, Wang WL, Shen Y, and Langley B. Searching for disease modifiers-PKC activation and HDAC inhibition. A dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress. Chem Med Chem 4: 1095-1105, 2009.
139. Krenz M, Oldenburg O, Wimpee H, Cohen MV, Garlid KD, Critz SD, Downey JM, and Benoit JN. Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol 97: 365-373, 2002.
140. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, and Sharpless NE. Ink4a=Arf expression is a biomarker of aging. J Clin Invest 114: 1299-1307, 2004.
141. Ku HH, Brunk UT, and Sohal RS. Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. Free Radic Biol Med 15: 621-627, 1993.
142. Lee S, Lynn EG, Kim JA, and Quon MJ. Protein kinase C-zeta phosphorylates insulin receptor substrate-1,-3, and-4 but not-2: Isoform specific determinants of specificity in insulin signaling. Endocrinology 149: 2451-2458, 2008.
143. Leitges M, Mayr M, Braun U, Mayr U, Li C, Pfister G, Ghaffari-Tabrizi N, Baier G, Hu Y, and Xu Q. Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice. J Clin Invest 108: 1505-1512, 2001.
144. Levade T and Jaffrezou JP. Signaling sphingomyelinases: Which, where, how and why? Biochim Biophys Acta 1438: 1-17, 1999.
145. Li X, Rong Y, Zhang M, Wang XL, LeMaire SA, Coselli JS, Zhang Y, and Shen YH. Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. Biochem Biophys Res Commun 381: 660-665, 2009.
146. Liberman Z, Plotkin B, Tennenbaum T, and Eldar-Finkel-man H. Coordinated phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 and protein ki-nase C betaII in the diabetic fat tissue. Am J Physiol En-docrinol Metab 294: E1169-1177, 2008.
147. Lin MT and Beal MF. Mitochondrial dysfunction and oxi-dative stress in neurodegenerative diseases. Nature 443: 787-795, 2006.
148. Lindsay DG and Astley SB. European research on the functional effects of dietary antioxidants\EUROFEDA. Mol Aspects Med 23: 1-38, 2002.
149. Liron T, Seraya CB, Ish-Shalom M, Souroujon MC, and Neumann D. Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels. Neuroscience 146: 152-159, 2007.
150. Liu J, Chen J, Dai Q, and Lee RM. Phospholipid scramblase 3 is the mitochondrial target of protein kinase C delta-induced apoptosis. Cancer Res 63: 1153-1156, 2003.
151. Liu YF, Paz K, Herschkovitz A, Alt A, Tennenbaum T, Sampson SR, Ohba M, Kuroki T, LeRoith D, and Zick Y. Insulin stimulates PKCzeta-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem 276: 14459-14465, 2001.
152. Livneh E, Shimon T, Bechor E, Doki Y, Schieren I, and Weinstein IB. Linking protein kinase C to the cell cycle: Ectopic expression of PKC eta in NIH3T3cells alters the expression of cyclins and Cdk inhibitors and induces adi-pogenesis. Oncogene 12: 1545-1555, 1996.
153. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, and Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 12: 57-65, 1998.
154. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, and Yankner BA. Gene regulation and DNA damage in the aging human brain. Nature 429: 883-891, 2004.
155. Lynch K, Fernandez G, Pappalardo A, and Peluso JJ. Basic fibroblast growth factor inhibits apoptosis of spontaneously immortalized granulosa cells by regulating in-tracellular free calcium levels through a protein kinase Cdelta-dependent pathway. Endocrinology 141: 4209-4217, 2000.
156. Maher P. How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J Neurosci 21: 2929-2938, 2001.
157. Maingrette F and Renier G. Leptin increases lipoprotein lipase secretion by macrophages: Involvement of oxidative stress and protein kinase C. Diabetes 52: 2121-2128, 2003.
158. Mansat V, Laurent G, Levade T, Bettaieb A, and Jaffrezou JP. The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res 57: 5300-5534, 1997.
159. Mansat-de Mas V, Bezombes C, Quillet-Mary A, Bettaieb A, D'Orgeix A D,
160. Mansat-De Mas V, de Thonel A, Gaulin V, Demur C, Laurent G, and Quillet-Mary A. Protein kinase C-zeta over-expression induces erythroid phenotype in the monocytic leukaemia cell line U937. Br J Haematol 118: 646-653, 2002.
161. Maruyama W, Akao Y, Youdim MB, Davis BA, and Naoi M. Transfection- enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R) salsolinol. J Neurochem 78: 727-735, 2001.
162. McGowan K, DeVente J, Carey JO, Ways DK, and Pekala PH. Protein kinase C isoform expression during the differentiation of 3T3-L1 preadipocytes: Loss of protein kinase C-alpha isoform correlates with loss of phorbol 12-myr-istate 13-acetate activation of nuclear factor kappaB and acquisition of the adipocyte phenotype. J Cell Physiol 167: 113-120, 1996.
163. Meijer AJ and Codogno P. Regulation and role of autop-hagy in mammalian cells. Int J Biochem Cell Biol 36: 2445-2462, 2004.
164. Mellor H and Parker PJ. The extended protein kinase C superfamily. Biochem J 332: 281-292, 1998.
165. Mezosi E, Szabo J, Nagy EV, Borbely A, Varga E, Paragh G, and Varga Z. Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes. J Endocrinol 185: 121-129, 2005.
166. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, and Pelicci PG. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402: 309-313, 1999.
167. Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH, and Mushinski JF. Overexpression of protein kinase C-delta and-epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumori-genicity. J Biol Chem 268: 6090-6096, 1993.
168. Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H, Ohno S, Hatakeyama S, and Nakayama KI. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 416: 865-869, 2002.
169. Mochly-Rosen D, Khaner H, Lopez J, and Smith BL. In-tracellular receptors for activated protein kinase C. Identification of a binding site for the enzyme. J Biol Chem 266: 14866-14868, 1991.
170. Montero M, Barrero MJ, and Alvarez J. [Ca2\+] microdo-mains control agonist-induced Ca2\+ release in intact HeLa cells. FASEB J. 11: 881-885, 1997.
171. Montero M, Lobaton CD, Gutierrez-Fernandez S, Moreno A, and Alvarez J. Modulation of histamine-induced Ca2\+ release by protein kinase C: Effects on cytosolic and mitochondrial [Ca2\+] peaks. J Biol Chem 278: 49972-49979, 2003.
172. Morel Y and Barouki R. Repression of gene expression by oxidative stress. Biochem J 342: 481-496, 1999.
173. Mori I, Ishizuka T, Morita H, Matsumoto M, Uno Y, Kajita K, Ikeda T, Fujioka K, and Matsubara K. Comparison of biochemical data, blood pressure and physical activity between longevity and non-longevity districts in Japan. Circ J 72: 1680-1684, 2008.
174. Murphy E and Steenbergen C. Preconditioning: The mito-chondrial connection. Annu Rev Physiol 69: 51-67, 2007.
175. Murriel CL, Churchill E, Inagaki K, Szweda LI, and Mochly-Rosen D. Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: A mechanism involving BAD and the mitochondria. J Biol Chem 279: 47985-47991, 2004.
176. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
177. Muruganandan S, Roman AA, and Sinal CJ. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: Cross talk with the osteoblastogenic program. Cell Mol Life Sci 66: 236-253, 2009.
178. Nagata S. Apoptosis by death factor. Cell 88: 355-365, 1997.
179. Nakagawa M, Oliva JL, Kothapalli D, Fournier A, Assoian RK, and Kazanietz MG. Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem 280: 33926-33934, 2005.
180. Nam JS, Cho MH, Lee GT, Park JS, Ahn CW, Cha BS, Lim SK, Kim KR, Ha HJ, and Lee HC. The activation of NF-kappaB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy. Diabetes Res Clin Pract 81: 25-32, 2008.
181. Nelson TJ, Sun MK, Hongpaisan J, and Alkon DL. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur J Pharmacol 585: 76-87, 2008.
182. Nishikawa T and Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 9: 343-353, 2007. (Pubitemid 46150966)
183. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hy-perglycaemic damage. Nature 404: 787-790, 2000.
184. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
185. O'Brian CA, Liskamp RM, Solomon DH, and Weinstein IB. Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462-2465, 1985.
186. O'Rourke B. Evidence for mitochondrial K\+ channels and their role in cardioprotection. Circ Res 94: 420-432, 2004.
187. Oancea E and Meyer T. Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell 95: 307-318, 1998.
188. Ogbi M, Chew CS, Pohl J, Stuchlik O, Ogbi S, and Johnson JA. Cytochrome c oxidase subunit IV as a marker of protein kinase Cepsilon function in neonatal cardiac myocytes: Implications for cytochrome c oxidase activity. Biochem J 382: 923-932, 2004.
189. Ohsumi Y. Molecular dissection of autophagy: Two ubiquitin-like systems. Nat Rev Mol Cell Biol 2: 211-216, 2001.
190. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, and Nishizuka Y. The structure, expression, and properties of additional members of the protein kinase C family. J Biol Chem 263: 6927-6932, 1988.
191. Orsini F, Migliaccio E, Moroni M, Contursi C, Raker VA, Piccini D, Martin-Padura I, Pelliccia G, Trinei M, Bono M, Puri C, Tacchetti C, Ferrini M, Mannucci R, Nicoletti I, Lanfrancone L, Giorgio M, and Pelicci PG. The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem 279: 25689-25695, 2004.
192. Osseni RA, Rat P, Bogdan A, Warnet JM, and Touitou Y. Evidence of prooxidant and antioxidant action of melato-nin on human liver cell line HepG2. Life Sci 68: 387-399, 2000.
193. Oster H and Leitges M. Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin=\+ mice. Cancer Res 66: 6955-6963, 2006.
194. Ostlund RE, Jr., Yang JW, Klein S, and Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 81: 3909-3913, 1996.
195. Ott M, Gogvadze V, Orrenius S, and Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 12: 913-922, 2007.
196. Pandey P, Nakazawa A, Ito Y, Datta R, Kharbanda S, and Kufe D. Requirement for caspase activation in monocytic differentiation of myeloid leukemia cells. Oncogene 19: 3941-3947, 2000.
197. Paola D, Domenicotti C, Nitti M, Vitali A, Borghi R, Cottalasso D, Zaccheo D, Odetti P, Strocchi P, Marinari UM, Tabaton M, and Pronzato MA. Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem Biophys Res Commun 268: 642-646, 2000.
198. Partridge NC, Bloch SR, and Pearman AT. Signal trans-duction pathways mediating parathyroid hormone regulation of osteoblastic gene expression. J Cell Biochem 55: 321-327, 1994.
199. Pascale A, Fortino I, Govoni S, Trabucchi M, Wetsel WC, and Battaini F. Functional impairment in protein kinase C by RACK1 (receptor for activated C kinase 1) deficiency in aged rat brain cortex. J Neurochem 67: 2471-2477, 1996.
200. Pastor MD, Garcia-Yebenes I, Fradejas N, Perez-Ortiz JM, Mora-Lee S, Tranque P, Moro MA, Pende M, and Calvo S. mTOR=S6 kinase pathway contributes to astrocyte survival during ischemia. J Biol Chem 284: 22067-22078, 2009.
201. Pearson P, Lewis SA, Britton J, Young IS, and Fogarty A. The pro-oxidant activity of high-dose vitamin E supplements in vivo. BioDrugs 20: 271-273, 2006.
202. Ping P, Zhang J, Pierce WM, Jr., and Bolli R. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotec-tion. Circ Res 88: 59-62, 2001.
203. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, and Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414, 1997.
204. Pinton P, Giorgi C, Siviero R, Zecchini E, and Rizzuto R. Calcium and apoptosis: ER-mitochondria Ca2\+ transfer in the control of apoptosis. Oncogene 27: 6407-6418, 2008.
205. Pinton P, Leo S, Wieckowski MR, Di Benedetto G, and Rizzuto R. Long-term modulation of mitochondrial Ca2\+ signals by protein kinase C isozymes. J Cell Biol 165: 223-232, 2004.
206. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, Contursi C, Minucci S, Mantovani F, Wieck-owski MR, Del Sal G, Pelicci PG, and Rizzuto R. Protein kinase C beta and prolyl isomerase 1 regulate mitochon-drial effects of the life-span determinant p66Shc. Science 315: 659-663, 2007.
207. Pinton P, Rimessi A, Romagnoli A, Prandini A, and Riz-zuto R. Biosensors for the detection of calcium and pH. Methods Cell Biol 80: 297-325, 2007.
208. Pinton P and Rizzuto R. p66Shc, oxidative stress and aging: Importing a lifespan determinant into mitochondria. Cell Cycle 7: 304-308, 2008.
209. Pinton P, Tsuboi T, Ainscow EK, Pozzan T, Rizzuto R, and Rutter GA. Dynamics of glucose-induced membrane recruitment of protein kinase C beta II in living pancreatic islet beta-cells. J Biol Chem 277: 37702-37710, 2002.
210. Poirier SN, Poitras M, Chorvatova A, Payet MD, and Guillemette G. FK506 blocks intracellular Ca2\+ oscillations in bovine adrenal glomerulosa cells. Biochemistry 40: 6486-6492, 2001.
211. Powell CT, Brittis NJ, Stec D, Hug H, Heston WD, and Fair WR. Persistent membrane translocation of protein kinase C alpha during 12-0- tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ 7: 419-428, 1996.
212. Prevostel C, Martin A, Alvaro V, Jaffiol C, and Joubert D. Protein kinase C alpha and tumorigenesis of the endocrine gland. Horm Res 47: 140-144, 1997.
213. Przyklenk K. Pharmacologic treatment of the stunned myocardium: The concepts and the challenges. Coron Artery Dis 12: 363-369, 2001.
214. Raab MS, Breitkreutz I, Tonon G, Zhang J, Hayden PJ, Nguyen T, Fruehauf JH, Lin BK, Chauhan D, Hideshima T, Munshi NC, Anderson KC, and Podar K. Targeting PKC: A novel role for beta-catenin in ER stress and apoptotic signaling. Blood 113: 1513-1521, 2009.
215. Racchi M, Govoni S, Solerte SB, Galli CL, and Corsini E. Dehydroepiandrosterone and the relationship with aging and memory: A possible link with protein kinase C functional machinery. Brain Res Brain Res Rev 37: 287-293, 2001.
216. Racchi M, Mazzucchelli M, Pascale A, Sironi M, and Go-voni S. Role of protein kinase Calpha in the regulated secretion of the amyloid precursor protein. Mol Psychiat 8: 209-216, 2003.
217. Raha S, Myint AT, Johnstone L, and Robinson BH. Control of oxygen free radical formation from mitochondrial complex I: Roles for protein kinase A and pyruvate dehydro-genase kinase. Free Radic Biol Med 32: 421-430, 2002.
218. Rask-Madsen C and King GL. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol 25: 487-496, 2005.
219. Rasola A and Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12: 815-833, 2007.
220. Ravichandran LV, Esposito DL, Chen J, and Quon MJ. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphati-dylinositol 3-kinase in response to insulin. J Biol Chem 276: 3543-3549, 2001.
221. Reaven GM. Insulin resistance: A chicken that has come to roost. Ann NY Acad Sci 892: 45-57, 1999.
222. Reddy PH, McWeeney S, Park BS, Manczak M, Gutala RV, Partovi D, Jung Y, Yau V, Searles R, Mori M, and Quinn J. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochon-drial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 13: 1225-1240, 2004.
223. Reiter RJ. Oxidative damage in the central nervous system: Protection by melatonin. Prog Neurobiol 56: 359-384, 1998.
224. Renier G, Desfaits AC, Lambert A, and Mikhail R. Role of oxidant injury on macrophage lipoprotein lipase (LPL) production and sensitivity to LPL. J Lipid Res 37: 799-809, 1996.
225. Reyland ME. Protein kinase Cdelta and apoptosis. Biochem Soc Trans 35: 1001-1004, 2007.
226. Reyland ME. Protein kinase C isoforms: Multi-functional regulators of cell life and death. Front Biosci 14: 2386-2399, 2009.
227. Rimessi A, Rizzuto R, and Pinton P. Differential recruitment of PKC isoforms in HeLa cells during redox stress. Cell Stress Chaperones 12: 291-298, 2007.
228. Rizzuto R, Marchi S, Bonora M, Aguiari P, Bononi A, De Stefani D, Giorgi C, Leo S, Rimessi A, Siviero R, Zecchini E, and Pinton P. Ca(2\+) transfer from the ER to mitochondria: When, how and why. Biochim Biophys Acta 1787: 1342-1351, 2009.
229. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, and Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17: 189-212, 2001.
230. Rossner S, Mendla K, Schliebs R, and Bigl V. Protein kinase Calpha and beta1 isoforms are regulators of alpha-secretory proteolytic processing of amyloid precursor protein in vivo. Eur J Neurosci 13: 1644-1648, 2001.
231. Rozengurt E. Early signals in the mitogenic response. Science 234: 161-166, 1986.
232. Russell JH. Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 7: 382-388, 1995.
233. Ruvolo PP, Deng X, Carr BK, and May WS. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 273: 25436-25442, 1998.
234. Sakaki K and Kaufman RJ. Regulation of ER stress-induced macroautophagy by protein kinase C. Autophagy 4: 841-843, 2008.
235. Sakaki K, Wu J, and Kaufman RJ. Protein kinase Ctheta is required for autophagy in response to stress in the endo-plasmic reticulum. J Biol Chem 283: 15370-15380, 2008.
236. Salvemini D, Muscoli C, Riley DP, and Cuzzocrea S. Su-peroxide dismutase mimetics. Pulm Pharmacol Ther 15: 439-447, 2002.
237. Santos-Alvarez J, Goberna R, and Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194: 6-11, 1999.
238. Sato T, O'Rourke B, and Marban E. Modulation of mito-chondrial ATP-dependent K\+ channels by protein kinase C. Circ Res 83: 110-114, 1998.
239. Saurin AT, Pennington DJ, Raat NJ, Latchman DS, Owen MJ, and Marber MS. Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res 55: 672-680, 2002.
240. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, and Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1: 1269, 1989.
241. Schechtman D and Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20: 6339-6347, 2001.
242. Schwartz GK, Jiang J, Kelsen D, and Albino AP. Protein kinase C: A novel target for inhibiting gastric cancer cell invasion. J Natl Cancer Inst 85: 402-407, 1993.
243. Slater SJ, Kelly MB, Taddeo FJ, Larkin JD, Yeager MD, McLane JA, Ho C, and Stubbs CD. Direct activation of protein kinase C by 1 alpha,25- dihydroxyvitamin D3. J Biol Chem 270: 6639-6643, 1995.
244. Slezak J, Tribulova N, Pristacova J, Uhrik B, Thomas T, Khaper N, Kaul N, nd Singal PK. Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol 147: 772-781, 1995.
245. Sohal RS, Mockett RJ, and Orr WC. Mechanisms of aging: An appraisal of the oxidative stress hypothesis. Free Radic Biol Med 33: 575-586, 2002.
246. Souroujon MC and Mochly-Rosen D. Peptide modulators of protein-protein interactions in intracellular signaling. Nat Biotechnol 16: 919-924, 1998.
247. Stabel S and Parker PJ. Protein kinase C. Pharmacol Ther 51: 71-95, 1991.
248. Sun B, Murray NR, and Fields AP. A role for nuclear phosphatidylinositol- specific phospholipase C in the G2=M phase transition. J Biol Chem 272: 26313-26317, 1997. (Pubitemid 27458844)
249. Sun MK and Alkon DL. Protein kinase C pharmacology: Perspectives on therapeutic potentials as antidementic and cognitive agents. Recent Pat CNS Drug Discov 1: 147-156, 2006.
250. Sun MK, Hongpaisan J, Nelson TJ, and Alkon DL. Post-stroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains. Proc Natl Acad Sci USA 105: 13620-13625, 2008.
251. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-1269, 1995.
252. Supattapone S, Danoff SK, Theibert A, Joseph SK, Steiner J, and Snyder SH. Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proc Natl Acad Sci USA 85: 8747-8750, 1988.
253. Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI, Ide T, Saya H, and Hara E. Mitogenic signaling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 8: 1291-1297, 2006.
254. Takai Y, Kishimoto A, Inoue M, and Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem 252: 7603-7609, 1977. (Pubitemid 8227336)
255. Takekoshi K, Ishii K, Nanmoku T, Shibuya S, Kawakami Y, Isobe K, and Nakai T. Leptin stimulates catecholamine synthesis in a PKC-dependent manner in cultured porcine adrenal medullary chromaffin cells. Endocrinology 142: 4861-4871, 2001.
256. Talior I, Tennenbaum T, Kuroki T, and Eldar-Finkelman H. PKC-delta-dependent activation of oxidative stress in adi-pocytesof obese and insulin-resistant mice: Role for NADPH oxidase. Am J Physiol Endocrinol Metab 288: E405-11, 2005.
257. Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Gu-glielmotto M, Santoro G, Davit A, Danni O, Smith MA, Perry G, and Tabaton M. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem 92: 628-636, 2005.
258. Tapia G, Fernandez V, Varela P, Cornejo P, Guerrero J, and Videla LA. Thyroid hormone-induced oxidative stress triggers nuclear factor-kappaB activation and cytokine gene expression in rat liver. Free Radic Biol Med 35: 257-265, 2003.
259. Taylor CG, Nagy LE, and Bray TM. Nutritional and hormonal regulation of glutathione homeostasis. Curr Top Cell Regul 34: 189-208, 1996.
260. Thompson LJ and Fields AP. betaII protein kinase C is required for the G2=M phase transition of cell cycle. J Biol Chem 271: 15045-15053, 1996.
261. Toker A. Signaling through protein kinase C. Front Biosci 3: D1134-1147, 1998.
262. Tomai F. Warm up phenomenon and preconditioning in clinical practice. Heart 87: 99-100, 2002.
263. Tracy K and Macleod KF. Regulation of mitochondrial integrity, autophagy and cell survival by BNIP3. Autophagy 3: 616-619, 2007.
264. Tuttle KR. Protein kinase C-beta inhibition for diabetic kidney disease. Diabetes Res Clin Pract 82: S70-74, 2008.
265. Verma S, Fedak PW, Weisel RD, Butany J, Rao V, Maitland A, Li RK, Dhillon B, and Yau TM. Fundamentals of re-perfusion injury for the clinical cardiologist. Circulation 105: 2332-2336, 2002. (Pubitemid 34556381)
266. Villalba M, Kasibhatla S, Genestier L, Mahboubi A, Green DR, and Altman A. Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death. J Immunol 163: 5813-5819, 1999.
267. Walker WG, Whelton PK, Saito H, Russell RP, and Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1: 287-291, 1979.
268. Wang Y, Takashi E, Xu M, Ayub A, and Ashraf M. Downregulation of protein kinase C inhibits activation of mitochondrial K(ATP) channels by diazoxide. Circulation 104: 85-90, 2001.
269. Ward NE, Pierce DS, Chung SE, Gravitt KR, and O'Brian CA. Irreversible inactivation of protein kinase C by gluta-thione. J Biol Chem 273: 12558-12566, 1998.
270. Watanabe T, Ono Y, Taniyama Y, Hazama K, Igarashi K, Ogita K, Kikkawa U, and Nishizuka Y. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proc Natl Acad Sci USA 89: 10159-10163, 1992.
271. Watson JA, Rumsby MG, and Wolowacz RG. Phage display identifies thioredoxin and superoxide dismutase as novel protein kinase C-interacting proteins: Thioredoxin inhibits protein kinase C-mediated phosphorylation of histone. Biochem J 343: 301-305, 1999.
272. Way KJ, Katai N, and King GL. Protein kinase C and the development of diabetic vascular complications. Diabet Med 18: 945-959, 2001.
273. Wheaton K and Riabowol K. Protein kinase C delta blocks immediate-early gene expression in senescent cells by inactivating serum response factor. Mol Cell Biol 24: 7298-7311, 2004.
274. Whelan RD and Parker PJ. Loss of protein kinase C function induces an apoptotic response. Oncogene 16: 1939-1944, 1998.
275. Wiernsperger NF and Bailey CJ. The antihyperglycaemic effect of metformin: Therapeutic and cellular mechanisms. Drugs 58: 31-39; discussion 75-82, 1999.
276. Willey JC, Grafstrom RC, Moser CE, Jr., Ozanne C, Sund-quvist K, and Harris CC. Biochemical and morphological effects of cigarette smoke condensate and its fractions on normal human bronchial epithelial cells in vitro. Cancer Res 47: 2045-2049, 1987.
277. Wu WS, Tsai RK, Chang CH, Wang S, Wu JR, and Chang YX. Reactive oxygen species mediated sustained activation of protein kinase C alpha and extracellular signal-regulated kinase for migration of human hepatoma cell Hepg2. Mol Cancer Res 4: 747-758, 2006.
278. Wulf G, Finn G, Suizu F, and Lu KP. Phosphorylation-specific prolyl isomerization: Is there an underlying theme? Nat Cell Biol 7: 435-441, 2005.
279. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, and Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276: 25096-25100, 2001.
280. Yang XM, Sato H, Downey JM, and Cohen MV. Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation. J Mol Cell Cardiol 29: 991-999, 1997.
281. Yu H, Oh-Hashi K, Tanaka T, Sai A, Inoue M, Hirata Y, and Kiuchi K. Rehmannia glutinosa induces glial cell line-derived neurotrophic factor gene expression in astroglial cells via cPKC and ERK1=2 pathways independently. Pharmacol Res 54: 39-45, 2006.
282. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, Gonzalez FJ, and Semenza GL. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283: 10892-10903, 2008.
283. Zhou W, Takuwa N, Kumada M, and Takuwa Y. Protein kinase C-mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation, and cyclin-dependent kinases in human vascular endothelial cells. J Biol Chem 268: 23041-23048, 1993.
284. Zhou Y, Wang D, Li F, Shi J, and Song J. Different roles of protein kinase C-betaI and-delta in the regulation of adipo-cyte differentiation. Int J Biochem Cell Biol 38: 2151-2163, 2006.
285. Zhu DM, Fang WH, Narla RK, and Uckun FM. A requirement for protein kinase C inhibition for calcium-triggered apoptosis in acute lymphoblastic leukemia cells. Clin Cancer Res 5: 355-360, 1999.
286. Zhu GH, Wong BC, Slosberg ED, Eggo MC, Ching CK, Yuen ST, Lai KC, Soh JW, Weinstein IB, and Lam SK. Overexpression of protein kinase C-beta1 isoenzyme suppresses indomethacin-induced apoptosis in gastric epithelial cells. Gastroenterology 118: 507-514, 2000.
287. Zorov DB, Filburn CR, Klotz LO, Zweier JL, and Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochon-drial permeability transition in cardiac myocytes. J Exp Med 192: 1001-1014, 2000.